I now have comprehensive information to craft a thorough answer. Let me compile everything.
Chemo Brain & the Role of Occupational Therapy
What Is Chemo Brain?
Chemotherapy-related cognitive impairment (CRCI) — colloquially called "chemo brain" or "chemo fog" — refers to a constellation of cognitive changes experienced by cancer patients during or after chemotherapy. It affects nearly 35% of all cancer survivors and has a profound impact on functional ability and health-related quality of life.
Harrison's Principles of Internal Medicine 22E (2025), p. 800
Clinical Features
Patients report subjective cognitive complaints that often exceed what objective neuropsychological testing detects, partly because standardised tests are performed under optimal conditions and may not reflect real-life functional demands.
Cognitive domains affected:
- Working memory and learning
- Attention and concentration
- Executive functioning (planning, multitasking)
- Speed of information processing
Temporal pattern:
- Acute changes are common during active treatment
- Long-term posttreatment changes persist in 17–34% of patients
- Most symptoms improve within 1 year, but 10–20% experience prolonged impairment
Kaplan & Sadock's Comprehensive Textbook of Psychiatry, p. 7086–7087
Pathophysiology
Multiple mechanisms are implicated:
| Mechanism | Details |
|---|
| Direct neurotoxicity | Chemotherapy agents crossing the blood-brain barrier directly injure neural tissue |
| Oxidative damage | Free radical generation damages neurons and white matter |
| Immune dysregulation / cytokine production | Pro-inflammatory cytokines impair neural signalling |
| Neurodegeneration | Reduction in volume of brain structures; white matter tract changes on imaging |
| Genetic susceptibility | Polymorphisms in APOE and BDNF genes increase vulnerability |
Harrison's 22E, p. 800; Kaplan & Sadock, p. 7086–7087
Assessment
- Neuropsychological battery — standardised tests for memory, attention, processing speed, executive function; compared to normative data or pre-treatment baseline
- Self-report measures — often detect greater subjective impairment than objective tests; discrepancy may reflect anxiety/depression or the inability of tests to capture real-world performance
- Neuroimaging — MRI shows reduced brain structure volumes and white matter integrity changes
- Premorbid cognitive function must be established as a comparison baseline
Medical Management
No clearly effective pharmacological therapy exists. Studied agents with inconclusive evidence include:
- Methylphenidate (and psychostimulants — may help attention/executive function in some populations)
- Erythropoietin
- Ginkgo biloba
- Cholinesterase inhibitors
Regular exercise and cognitive rehabilitation are the most consistently supported non-pharmacological approaches.
Harrison's 22E, p. 800; Kaplan & Sadock, p. 7087
Role of Occupational Therapy (OT)
Occupational therapy is central to the rehabilitation of chemo brain because it bridges the gap between laboratory cognitive testing and real-world functional performance — precisely the gap that standard neuropsychological tests fail to capture.
OT Assessment
- Occupational performance analysis in daily life tasks (work, home management, self-care)
- Functional cognitive assessments sensitive to real-world demands
- Identifying which cognitive deficits create the most occupational disruption
Core OT Intervention Strategies
1. Cognitive Strategy Training
- Internal strategies: mnemonics, chunking, mental retracing
- External compensatory strategies: planners, calendars, reminder apps, structured routines
- Errorless learning techniques
2. Activity Modification and Environmental Adaptation
- Simplifying complex tasks into steps
- Reducing environmental distractions
- Modifying workspaces to reduce cognitive load
3. Energy Conservation and Pacing
- Cognitive fatigue is closely linked to chemo brain; pacing prevents exhaustion that worsens cognition
4. Psychoeducation
- Normalising the experience of chemo brain
- Teaching patients and carers strategies to manage cognitive symptoms day-to-day
5. Return-to-Work Rehabilitation
- Graded return-to-work planning, workplace accommodations, liaison with employers
- Internet-based cognitive rehabilitation programs for working cancer survivors show promising results (PMID: 39793002)
6. Combined Technological Interventions (Emerging)
- Transcranial Direct Current Stimulation (tDCS) combined with OT has shown potential but requires further research in this population
Evidence Base
A 2026 systematic review in the American Journal of Occupational Therapy (Castelao-Alburquerque et al.) specifically evaluated OT interventions for chemo brain in breast cancer patients:
- OT interventions showed a positive trend in improving occupational performance, cognitive function (memory, attention), and quality of life
- The combination of technological and occupational interventions (e.g., tDCS + OT) had the strongest impact on functional recovery
- tDCS alone is promising but underexplored in this population
Why OT Is Uniquely Positioned
| Challenge of Chemo Brain | OT's Response |
|---|
| Deficits show up in daily life, not in a testing room | OT assesses and trains functional, real-world performance |
| Patients struggle at work | Vocational rehabilitation and workplace modifications |
| Subjective experience > objective scores | OT validates lived experience and targets meaningful activities |
| Multiple interacting factors (fatigue, mood, cognition) | Holistic, occupation-centred approach |
| Long recovery trajectory | Ongoing adaptive strategy training across phases of survivorship |
Summary
Chemo brain is a prevalent, multimechanistic cognitive syndrome affecting cancer survivors that conventional medicine has limited pharmacological tools to treat. Occupational therapy directly addresses the functional and occupational consequences of CRCI — through compensatory strategy training, environmental modification, psychoeducation, and return-to-work support — and is supported by emerging systematic review evidence as an effective, patient-centred intervention.
Sources: Harrison's Principles of Internal Medicine 22E, p. 800; Kaplan & Sadock's Comprehensive Textbook of Psychiatry, pp. 7086–7089; Castelao-Alburquerque et al., Am J Occup Ther 2026 (PMID 41609482)